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Abstract Ca2+ signaling is important for many cellular and physiological processes, including
cardiac function. Although sarcoplasmic reticulum (SR) proteins involved in Ca2+ signaling have
been shown to be phosphorylated, the biochemical and physiological roles of protein
phosphorylation within the lumen of the SR remain essentially uncharacterized. Our laboratory
recently identified an atypical protein kinase, Fam20C, which is uniquely localized to the secretory
pathway lumen. Here, we show that Fam20C phosphorylates several SR proteins involved in Ca2+
signaling, including calsequestrin2 and Stim1, whose biochemical activities are dramatically
regulated by Fam20C mediated phosphorylation. Notably, phosphorylation of Stim1 by Fam20C
enhances Stim1 activation and store-operated Ca2+ entry. Physiologically, mice with Fam20c
ablated in cardiomyocytes develop heart failure following either aging or induced pressure
overload. We extended these observations to show that non-muscle cells lacking Fam20C display
altered ER Ca2+ signaling. Overall, we show that Fam20C plays an overarching role in ER/SR Ca2+
homeostasis and cardiac pathophysiology.
DOI: https://doi.org/10.7554/eLife.41378.001
Introduction
Heart failure remains the leading cause of death in the United States (Benjamin et al., 2018) and is
clinically characterized by reduced cardiac function and pathological remodeling. Intracellular cal-
cium (Ca2+) handling is the basis of cardiac contraction and relaxation (Bers, 2014). Contraction
involves the release of sarcoplasmic reticulum (SR) Ca2+ into the cytosol via the ryanodine receptor 2
(RyR2); relaxation occurs with SR Ca2+ uptake by the sarco/endoplasmic reticulum Ca2+ ATPase
pump (SERCA2a) (Bers, 2002). Multiple proteins and post-translational modifications tightly regulate
this SR Ca2+ cycling, including phosphorylation of proteins on the cytosolic face of the SR (Ai et al.,
2005; Anderson et al., 2011; Chaanine and Hajjar, 2011), and are a focus of several clinical
attempts to improve cardiac function (Marks, 2013; Hulot et al., 2016). In addition, endoplasmic
reticulum (ER) Ca2+ signaling underlies a broad range of cellular process in a variety of tissues
(Raffaello et al., 2016). Importantly, the biochemical and physiological roles of protein
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phosphorylation within the ER/SR remains essentially unknown. Here we describe a luminal ER/SR
kinase that is important for cellular Ca2+ signaling and cardiac pathophysiology.
While studies of protein phosphorylation focus, almost exclusively, on the role of kinases in the
nucleus and cytoplasm of cells, many important secretory proteins are also phosphorylated
(Zhou et al., 2009). For over 100 years the identification of the physiological kinase that phosphory-
lates secretory proteins, such as b-casein, the most abundant phosphoprotein in milk, remained a
mystery (Tagliabracci et al., 2013). The discovery of the atypical kinase Fam20C solved this conun-
drum, as Fam20C has a signal peptide that brings it to the lumen of the secretory pathway where it
preferentially phosphorylates Ser within Ser-x-Glu/pSer (S-x-E) motifs (Tagliabracci et al., 2012).
Fam20C is important for bone and teeth formation in patients (Simpson et al., 2007; Cui et al.,
2015) and animal models (Vogel et al., 2012). Subsequent studies demonstrated that Fam20C is
responsible for generating >90% of the secreted phosphoproteome and that its substrates are likely
involved in diverse biological functions that mostly remain uncharacterized (Tagliabracci et al.,
2015).
Fam20C’s potential role in cardiac function was highlighted by the identification of a heart dis-
ease-associated polymorphism in luminal SR resident histidine-rich Ca2+-binding protein (HRC)
(Arvanitis et al., 2008; Singh et al., 2013). Specifically, this polymorphism (HRC-Ser96Ala) was
observed within a Fam20C consensus S-x-E phosphorylation motif and Fam20C was responsible for
HRC-Ser96 phosphorylation (Pollak et al., 2017). This phosphorylation modulated HRC’s interac-
tions with triadin and SERCA2a and was demonstrated to be necessary to prevent arrhythmias in
vitro. However, Fam20C’s physiological role in normal and diseased heart function remains unknown.
Importantly, we hypothesize that several SR Ca2+ regulatory proteins are Fam20C substrates, given
the extent of SR proteins containing S-x-E motifs and that Fam20C has been shown to be responsi-
ble for the majority of secretory pathway phosphorylation in several cell types (Tagliabracci et al.,
2015).
This study identifies, mechanistically, several critical ER/SR proteins as substrates of Fam20C, and
demonstrates Fam20C’s broad impact on cellular Ca2+ signaling in cardiomyocytes and other cell
types. Notably, we show that stromal interaction molecule 1 (Stim1), which is important for control-
ling cellular Ca2+ content in many cell types (Collins et al., 2013), and calsequestrin 2 (CSQ2), the
major Ca2+ binding protein in the SR, are dramatically regulated by Fam20C phosphorylation. We
then developed a cardiomyocyte-specific Fam20c conditional knockout (cKO) mouse model to
determine the physiological roles of SR luminal protein phosphorylation. Upon numerous pathologi-
cal stimuli, we demonstrate that Fam20C deficiency in cardiomyocytes results in dilated cardiomyop-
athy (DCM). DCM involves left ventricle (LV) dilation and reduced functional capacity in both human
and animal models (Hershberger et al., 2013). A better fundamental understanding of the underly-
ing molecular biologic mechanisms of these processes is critical to improving patient outcomes.
Results
Fam20C phosphorylates multiple SR regulatory proteins important for
Ca2+ homeostasis
Given the dramatic biochemical effects of Fam20C phosphorylation of HRC-Ser96 (Pollak et al.,
2017), we postulated that Fam20C phosphorylation of other SR proteins would have important reg-
ulatory functions. Therefore, we sought to uncover new Fam20C substrates to determine the overall
mechanistic role of Fam20C phosphorylation in the SR lumen. Focusing on luminal SR proteins that
have been shown to regulate Ca2+ signaling in cardiac function, we identified several proteins that
contain S-x-E motifs and are, therefore, potential Fam20C substrates; this includes calsequestrin 2
(CSQ2) (Houle et al., 2004), stromal interaction molecule 1 (Stim1) (Collins et al., 2013), calumenin
(Sahoo and Kim, 2010), sarcalumenin (Yoshida et al., 2005), calreticulin (Wang et al., 2012), and
triadin (Terentyev et al., 2005).
We engineered triadin, calumenin, calreticulin, and sarcalumenin, each with a C-terminal FLAG-
epitope tag, and co-expressed each of them with HA-epitope tagged Fam20C WT or a catalytically
inactive Fam20C mutant, D478A, referred to as Fam20C kinase-inactive (KI) (Tagliabracci et al.,
2012), in HEK293 cells, followed by 32P-orthophosphate labeling (Figure 1A). Following Flag-immu-
noprecipitation of cell extracts, immunoblotting, and autoradiography, each of these proteins was
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determined to be phosphorylated by WT Fam20C. It is likely that these phosphorylations will have
multifaceted contributions to ER/SR Ca2+ regulation (see discussion). We note that triadin (and Stim-
1, below) is known to be phosphorylated on its cytosolic portion, explaining the background in signal
in the Fam20C KI lane. Next, we chose to focus on CSQ2 (Houle et al., 2004) and Stim1
(Collins et al., 2013) given the significance of their physiological roles.
CSQ2 is the primary Ca2+ binding protein in the SR and is important for SR Ca2+ regulation and
cardiac pathophysiology (Gyo¨rke and Terentyev, 2008; Faggioni and Knollmann, 2012). It is
intriguing that CSQ2 has a single, conserved S-x-E site (Ser385) on its C-terminal tail (Figure 1B), the
region of the protein necessary for proper Ca2+ binding (Shin et al., 2000) and polymerization
(Park et al., 2003). Transfection of Flag-tagged WT and Ser385Ala mutant CSQ2 constructs into
Figure 1. Fam20C phosphorylates luminal SR proteins and regulates CSQ2 polymerization. (A) Representative
autoradiograph and Flag immunoblot (IB) of Flag immunoprecipitates (IPs) of 32P-orthophosphate-labeled HEK293
cells co-expressing HA-tagged WT or D478A kinase-inactive (KI) Fam20C with the indicated substrates (n = 3). (B)
Residues of Calsequestrin 2 (CSQ2) corresponding to the only Fam20C S-x-E phosphorylation motif on the protein
are highlighted in blue. (C) Representative autoradiograph and Flag IB of Flag IPs of 32P-orthophosphate-labeled
rat cardiomyoblast H9C2 cells expressing the indicated variant of CSQ2 (n = 3). (D) Representative autoradiograph
of time-dependent incorporation of [g-32P] ATP into CSQ2 using purified proteins in an in vitro kinase assay (n = 3).
CSQ2-His was expressed and purified from E. coli and Fam20C WT or KI was purified from baculovirus.
Corresponding IB of a-His is shown below. (E) Turbidity of un- and phosphorylated-CSQ2 as measured by
absorbance at 350 nm (n = 3). (F) Model demonstrating the consequence of Fam20C phosphorylation of CSQ2.
DOI: https://doi.org/10.7554/eLife.41378.002
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Figure 2. Fam20C phosphorylation of Stim1 regulates Stim1 activation (A) Residues of Stim1 from the canonical Ca2+-binding EF-hand loop
corresponding to the Fam20C S-x-E phosphorylation motif are highlighted in blue. Heart disease associated Stim1-Ser88 is noted with an asterisk (h:
human, m: mouse, g: gallus, x: xenopus, d: drosophila). (B) Representative autoradiograph and Flag IB of Flag IPs of 32P-orthophosphate-labeled
HEK293 cells co-expressing Stim1-Flag and HA-tagged WT or D478A kinase-inactive (KI) Fam20C (n = 3). (C) Representative autoradiograph of time-
dependent incorporation of [g-32P] ATP into Stim one using purified proteins in an in vitro kinase assay. His-tagged Stim1 was expressed and purified
Figure 2 continued on next page
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H9C2 rat myoblast cardiac cells, followed by 32P-orthophosphate labeling, revealed that only WT
CSQ2 was phosphorylated (Figure 1C), suggesting that CSQ2-Ser385 is phosphorylated. We then
purified recombinant His-tagged CSQ2 from E. coli and performed an in vitro kinase assay with puri-
fied recombinant Fam20C and 32P-labeled ATP (Figure 1D). Mutation of CSQ2 Ser385 to Ala abro-
gated phosphorylation, but mutation of Ser393 to Ala did not, suggesting that Fam20C
phosphorylates CSQ2 only at Ser385.
We sought to determine if Fam20C phosphorylation of CSQ2 affected CSQ2’s ability to polymer-
ize, which is critical to its functional roles (Faggioni and Knollmann, 2012). To study this, we
employed a turbidity assay (Sanchez et al., 2011), where absorbance at 350 nM was monitored as a
function of Ca2+, using CSQ2 that was either unphosphorylated or phosphorylated in vitro by
Fam20C (Figure 1E). Indeed, we found that phosphorylated CSQ2 showed a greater propensity to
form higher order polymeric structures than unphosphorylated CSQ2 (Figure 1E and F).
Stim1 is an ER/SR luminal Ca2+ sensor that regulates store-operated Ca2+ entry (SOCE) and other
Ca2+ sensing mechanisms in a variety of cell types (Soboloff et al., 2012; Be´nard et al., 2016),
including cardiomyocytes, where it plays a role in preventing heart failure following induced pressure
overload or aging (Be´nard et al., 2016). We identified a conserved S-x-E site in the Ca2+-binding
EF-hand region of the luminal portion of Stim1 (Figure 2A) (Stathopulos et al., 2008). Stim1 was
shown to be phosphorylated by Fam20C in cells and in vitro (Figure 2B and C) using the same tech-
niques as above (Figure 1). In addition, Stim1-Ser88Gly (Figure 2A), a mutation recently discovered
in a patient with heart disease (Harris et al., 2017) (see discussion), is less robustly phosphorylated
than Stim1-WT in vitro and in cells (Figure 2C,D and E), suggesting that Fam20C phosphorylates
Stim1-Ser88. Next, we employed a recently developed approach to measure Stim1 activity in ER
membranes that relies on an engineered cysteine in Stim1 (A230C) to capture the conformational
change involving the interaction between paired luminal domains that accompanies its activation
(Hirve et al., 2018). Stim1 activation involves a dramatic reorganization of the protein complex,
where the transmembrane regions of two Stim1 molecules (where the engineered cysteine are) align
close together, allowing the complex to extend and activate plasma membrane Ca2+ channels
(Hirve et al., 2018). We determined that over-expression of WT Fam20C in cells caused significantly
increased Stim1 activation under physiological Ca2+ levels in comparison to the catalytically inactive
KI Fam20C (Figure 2F and G). Taken together, phosphorylation of Ca2+ handling proteins in the ER/
SR by Fam20C is likely playing an important and complex regulatory role.
Fam20C regulates SR Ca2+ handling in isolated myocytes
Given that Fam20C phosphorylates proteins that reside in the lumen of the SR (Figures 1 and 2), we
hypothesized that Fam20C plays a role in cardiomyocyte SR Ca2+ handling. To determine this, we
developed a mouse model with LoxP sites engineered between exons 6 and 10 of Fam20c
(Fam20cFl/FL) (Figure 3—figure supplement 1). We crossed these mice with a-MHC-Cre mice to
knockout Fam20C in ventricular myocytes, generating Fam20cFl/FLa-MHC-Cre-positive (Fam20C
cKO) mice and Fam20cFl/FLa-MHC-Cre-negative (Fam20C WT) littermates. Importantly, we previ-
ously showed that this a-MHC-Cre mouse line has normal cardiac function following aging
(Fang et al., 2017).
We examined intracellular Ca2+ transients and cell shortening of isolated cardiomyocytes from
Fam20C cKO and WT mice paced at 0.5 Hz field stimulation (Figure 3A and B). We analyzed both
baseline (2 months old) and 9 months old aged mice, which can be more predisposed to compro-
mised cardiac function (Be´nard et al., 2016). A decrease in the peak amplitude (Figure 3C),
Figure 2 continued
from E. coli, and Fam20C WT or KI was purified from baculovirus (n = 6). Corresponding coomassie staining is shown below. (D) Representative
autoradiograph and Flag IB of Flag IPs of 32P-orthophosphate-labeled HEK293 cells co-expressed with Stim1 and WT Fam20C (n = 6). (E) Densitometry
relative to protein control of autoradiograph from C and D (at 30 min time point). (F) Representative western blots showing the crosslinking of Stim1
(A230C) co-expressed with either Fam20C KI (top), or Fam20C WT (bottom), in cellular membranes incubated with increasing Ca2+ concentrations (0–
2.0 mM) (n = 3). Crosslinked, multimerized (active) Stim one is indicated by the upper arrow, and monomeric (inactive) Stim1 is indicated by the lower
arrow. (G) Model demonstrating Stim1 activation via either low ER Ca2+ or Fam20C phosphorylation. Data are represented as the mean ±SEM.
*p < 0.05 by Student’s t test.
DOI: https://doi.org/10.7554/eLife.41378.003
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corresponding to the extent of SR Ca2+ release, and an increase in the relaxation constant tau
(Figure 3C), corresponding to the time it takes for SR Ca2+ reuptake, was observed for the Ca2+
transients of 9 months old Fam20C deficient cardiomyocytes in comparison to controls. Similar
results were obtained for the cell shortening measurements (Figure 3D). We note mildly reduced
cardiomyocyte function at baseline. Strikingly, following aging-induced stress we identified severe
cardiomyocyte defects from Fam20C deficiency, particularly in cardiomyocyte relaxation, which is
likely causative of aging-induced diastolic heart failure (see below). These results establish Fam20C
as an important regulator of SR Ca2+cycling in stressed cardiomyocytes.
Fam20C regulates cardiac relaxation and contractility
Based on the cardiomyocyte Ca2+cycling defects observed from Fam20C cKO mice upon aging (Fig-
ure 3), we sought to determine the role of Fam20C in contractility and relaxation in vivo via invasive
Figure 3. Fam20C regulates Ca2+ handling in isolated cardiomyocytes. (A and B) Tracing of 0.5 Hz stimulated isolated cardiomyocytes for (A) Ca2+
transients (change between the basal and peak ratio (DR) of Fura2-AM fluorescence) and (B) sarcomere length for 2 (top) and 9 (bottom) months old
mice. (C) Quantitation of normalized peak amplitude (left) and relaxation constant tau (right) of Ca2+ transients from A. (D) Quantitation of peak
amplitude changed (left) and relaxation constant tau (right) of sarcomere length from B (n = 3 mice, 15–25 cardiomyocytes per mice). Data are
represented as the mean ±SEM. *p < 0.05; **p < 0.01, by Student’s t test or ANOVA (when indicated) for WT v. cKO.
DOI: https://doi.org/10.7554/eLife.41378.004
The following figure supplement is available for figure 3:
Figure supplement 1. Generation of cardiac specific Fam20C cKO mice.
DOI: https://doi.org/10.7554/eLife.41378.005
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hemodynamic measurement of LV pressure. Contractility and relaxation are controlled by SR Ca2+
release and reuptake, respectively. At 2 months of age, we observe mild but statistically significant
defects of cardiac contractility (Max dP/dt) (Figure 4A) and relaxation (Min dP/dt) (Figure 4—figure
supplement 1A) in Fam20C cKO mice in comparison to WT mice, but no differences to the heart
rate and other hemodynamic parameters were observed (Figure 4—figure supplement 1B-D).
Upon 9 months of aging, relaxation was significantly blunted in Fam20C cKO mice (Figure 4—fig-
ure supplement 1A). The isovolumetric relaxation constant tau was dramatically higher (Figure 4B),
demonstrating delayed cardiac relaxation, and indicating overall diastolic dysfunction for 9 months
old Fam20C cKO mice, which is likely to cause heart failure (see below). Importantly, these results
are consistent with the in vitro data (Figure 3). Interestingly, we found that Fam20C’s role in contrac-
tility and relaxation is independent of acute b-adrenergic signaling in 2 months old mice, via infusion
of either dobutamine or esmolol (Schmid et al., 2015) (Figure 4—figure supplement 1).
Fam20C cKO mice develop heart failure, fibrosis, apoptosis, and DCM
following aging
Due to the defects observed in SR Ca2+ cycling (Figure 3) and cardiac relaxation and contractility
(Figure 4), we sought to determine Fam20C’s temporal role in cardiac function in vivo by performing
serial 2D echocardiography on mice who were from 2 to 9 months of age. Two and six months old
Fam20C cKO mice were indistinguishable from their WT littermates. However, following 9 months of
aging, Fam20C cKO mice displayed a decided increase in LV chamber size in both diastole and sys-
tole (Figure 5A). LV systolic function, as measured by fractional shortening (% FS), was dramatically
decreased in Fam20C cKO mice (Figure 5A), suggesting that these mice were developing heart fail-
ure. Depressed systolic function was accompanied by a thinning of the LV walls (Figure 5B). Further-
more, measurement by qRT-PCR on 9 months old Fam20C cKO mice showed significant increases in
the re-expression of fetal gene markers of cardiac hypertrophy and heart failure, including atrial
natriuretic factor (ANP), brain natriuretic peptide (BNP), and b-myosin heavy chain (b-MHC), in com-
parison to controls (Figure 5C). Gross morphological analysis showed enlarged hearts (Figure 6A),
consistent with the development of DCM following 9 months of aging. The observed heart failure in
the Fam20C cKO mice following aging is likely due to dramatic SR Ca2+ handling defects and
delayed cardiac relaxation (Figures 3 and 4).
Figure 4. Fam20C regulates cardiac contractility and relaxation in vivo. Hemodynamic assessment of contraction
and relaxation (n = 9–20). (A) Assessment of maximum pressure difference over time (dP/dt). (B) Assessment of the
isovolumetric relaxation constant tau. Data are represented as the mean ±SEM. *p < 0.05; **p < 0.01, by Student’s
t test or ANOVA (when indicated) for WT v. cKO.
DOI: https://doi.org/10.7554/eLife.41378.006
The following figure supplement is available for figure 4:
Figure supplement 1. Role of Fam20C in the acute hemodynamic response to b-adrenergic receptor activation.
DOI: https://doi.org/10.7554/eLife.41378.007
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Mouse hearts were dissected, fixed, and subjected to histological analysis by microscopy. In 2
months old Fam20C WT or cKO mice, no abnormalities or differences were identified. However, fol-
lowing 9 months of aging in the Fam20C cKO mice, Hematoxylin-Eosin (H and E) stained cardiac sec-
tions demonstrated ventricular dilation (Figure 6B), consistent with the echocardiographic analysis
(Figure 5A).
Cardiac fibrosis and apoptosis strongly associate with heart failure (Reed et al., 2011;
Segura et al., 2014). Using Masson’s Trichrome staining, we established that interstitial fibrosis was
greatly increased in Fam20C cKO mice, while WT mice demonstrated no signs of fibrosis following 9
months of aging (Figure 6C). Gravimetric analysis showed that the heart weight to body weight ratio
was greater in Fam20C cKO mice (Figure 6D). Terminal deoxynucleotidyltransferase-mediated dUTP
nick end labeling (TUNEL) staining demonstrated significantly more apoptotic nuclei in Fam20C cKO
mice (Figure 6D and Figure 6—figure supplement 1A). The amount of cleaved poly (ADP-ribose)
polymerase (PARP), a marker of apoptosis, was increased in Fam20C cKO heart lysates as deter-
mined by immunoblotting (Figure 6—figure supplement 1B). Finally, profibrotic gene expression
markers: a-smooth muscle actin (a-SMA), procollagen types I a1 (Coll-1a1) and III a1 (Coll-3a1), and
connective tissue growth factor (CTGF) were increased in Fam20C cKO mice upon aging (Figure 6—
figure supplement 1C).
Induced pressure overload causes accelerated heart failure in Fam20C
deficient mice
To determine Fam20C’s role in heart function during sustained pathological stress in vivo, we
employed the transverse aortic constriction (TAC)-induced pressure overload model (Figure 7). The
Figure 5. Fam20C cKO mice develop heart failure upon aging. (A and B) Echocardiographic measurements for Fam20CFl/Fl a-MHC-Cre-positive (cKO)
and a-MHC-Cre-negative littermate control mice (WT) (n = 10 mice at 2, 6, and 9 months) of (A) LVIDd, LVIDs, LV FS, (B) IVSd, and LVPWd. (C) RT-qPCR
of cardiac fetal gene markers of Fam20C WT and cKO mice at 2 and 9 months (n = 3). Data are represented as the mean ±SEM. *p < 0.05; **p < 0.01,
or ns (not significant) by Student’s t test or ANOVA (when indicated) for WT v. cKO.
DOI: https://doi.org/10.7554/eLife.41378.008
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TAC model, which causes hypertrophy and eventual heart failure (Rockman et al., 1991), is a more
targeted and immediately severe stressor than aging, and can directly test Fam20C’s role in the
hypertrophic response. The response to pressure overload for 4 weeks was similar between geno-
types (Figure 7—figure supplement 1A) of 2 months old Fam20C WT and cKO mice, both of which
developed LV wall thickening (Figure 7—figure supplement 1B and C). However, Fam20C cKO
mice developed significantly exaggerated LV chamber dilation (Figure 7A) and showed further dete-
rioration in cardiac function (Figure 7A) in comparison to their WT littermates. Gravimetric analysis
of isolated hearts showed that the heart weight to body weight ratio was higher in Fam20C cKO
mice (Figure 7B). Re-expression of cardiac fetal genes (Figure 7B) further confirmed the presence of
exaggerated heart failure in Fam20C cKO mice in comparison to WT littermates. We determined
Figure 6. Aging Fam20C cKO mice develop fibrosis, apoptosis, and DCM. (A) Representative macroscopic view
of whole mouse hearts. (B and C) Representative microscopic view of (B) H and E stained (1x magnification) and
(C) Masson’s Trichrome stained (40x magnification) cardiac sections (n = 3). (D) Heart weight to body weight ratios
(n = 5–13) (left). Quantitation of TUNEL positive nuclei per high powered field (HPF) (n = 3 mice) (right). Data are
represented as the mean ±SEM. *p < 0.05; **p < 0.01, by Student’s t test for WT v. cKO.
DOI: https://doi.org/10.7554/eLife.41378.009
The following figure supplement is available for figure 6:
Figure supplement 1. Aging Fam20C cKO mice develop apoptosis and fibrosis.
DOI: https://doi.org/10.7554/eLife.41378.010
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also that Fam20C cKO mice heart sections showed increased fibrosis (Figure 7C) and apoptosis (Fig-
ure 7—figure supplement 1D and E) following TAC.
To further evaluate Fam20C’s role in stress-induced cardiac remodeling, we administered chronic
b-adrenergic stimulation by isoproterenol infusion to Fam20C cKO and WT mice using mini-osmotic
pumps (Thum et al., 2008). After 2 weeks, Fam20C cKO mice showed a significantly increased heart
weight to body weight ratio (Figure 7D), and increased fetal gene re-expression (Figure 7D) in com-
parison to controls. Taken together, both TAC and isoproterenol infusion caused Fam20C cKO mice
Figure 7. Fam20C cKO mice develop heart failure following induced pressure overload. (A) Echocardiographic measurements for baseline (2 months
old) mice and after 4 weeks of TAC (n = 7–9) of LVIDd, LVIDs, and LV FS. (B) Heart weight to body weight ratios (n = 5–9) (left). RT-qPCR of cardiac fetal
gene markers following TAC (n = 3) (right). (C) Representative microscopic view of Masson’s Trichrome stained (40x magnification) cardiac sections
following TAC (n = 3 mice). (D) Mice were subjected to 2 weeks of chronic Isoproterenol (ISO) infusion (n = 5–9). Heart weight over body weight ratio
(n = 5–9) (left) and RT-qPCR of cardiac fetal gene markers (n = 3) (right). Data are represented as the mean ±SEM. *p < 0.05, **p < 0.01, for WT v. cKO;
† p < 0.05 for TAC or ISO treatment by Student’s t test.
DOI: https://doi.org/10.7554/eLife.41378.011
The following figure supplement is available for figure 7:
Figure supplement 1. Induced pressure overload causes hypertrophy, apoptosis in Fam20C cKO mice.
DOI: https://doi.org/10.7554/eLife.41378.012
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to develop an exaggerated depression of LV function in comparison to WT mice, reminiscent of the
aging model seen above.
Fam20C regulates ER Ca2+ homeostasis
Given that Fam20C is widely expressed in mammals (Nalbant et al., 2005) and that ER/SR Ca2+
homeostasis is important for many cell types, we sought to determine Fam20C’s role in cellular Ca2+
homeostasis in non-muscle cells. We transfected HeLa cells with either Flag-tagged WT or KI
Fam20C and tested for constitutive Ca2+ influx by briefly changing the external solution to 0 mM
Ca2+ and then back to 2 mM Ca2+ (Figure 8A), as previously described (Hirve et al., 2018). Only
the WT Fam20C transfected cells showed a significant increase over control HeLa cells in Ca2+ influx,
prior to thapsigargin stimulation which causes comparable Ca2+ influx for each sample. We note that
Fam20C mediated activation of Stim1 has an effect similar to Stim1 activating mutations
(Hirve et al., 2018). This indicates that Fam20C regulates store-operated Ca2+ entry, likely via acti-
vation of Stim1 (Figure 2E and F), but possibly through the phosphorylation of other ER substrates.
Moreover, this demonstrates that Fam20C plays a role in regulating cellular ER Ca2+ signaling.
Using an alternative approach to study Fam20C’s role in ER Ca2+ homeostasis, we treated cells
with thapsigargin, a SERCA inhibitor, which results in the release of ER Ca2+ stores (Wiley et al.,
2013). In WT and Fam20C shRNA knockdown (shFam20C) U2OS cell lines (Tagliabracci et al.,
2015) we observed that thapsigargin-induced release of ER Ca2+ was reduced upon Fam20C knock-
down (Figure 8B), showing Fam20C’s role in maintaining ER Ca2+ storage. Because dysregulation of
Figure 8. Fam20C regulates ER Ca2+ homeostasis. (A) Single-cell [Ca2+]i measurements in HeLa cells expressing
Fam20C WT (n = 156), Fam20C KI (n = 139), or in non-transfected HeLa cells (HeLa; n = 126). Cells were exposed
to solutions containing varied concentrations of CaCl2 or 1 mM thapsigargin (TG) as indicated. (B) Peak Ca
2+
release (maximum minus basal, peak ratio (DR) of Fura2-AM fluorescence) of WT and Fam20C shRNA knockdown
(shFam20C) U2OS cells following 2 mM thapsigargin (Tg) treatment. (C) RT-qPCR of UPR response gene CHOP
expression of WT and shRNA Fam20C knockdown U2OS cells following mild stimulation with thapsigargin (250
nM, 4 hr). Data are represented as the mean ±SEM. *p < 0.05; ***p < 0.001, by Student’s t test for WT v.
shFam20C.
DOI: https://doi.org/10.7554/eLife.41378.013
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ER Ca2+ induces the unfolded protein response (UPR) in cells, we assessed WT and shFam20C U2OS
cell lines for UPR induction using qRT-PCR to monitor levels of C/EBP homologous protein (CHOP),
a common UPR marker (Wiley et al., 2013) (Figure 8C). There was no basal UPR detected; however,
shFam20C U2OS cells showed a robust expression of CHOP following stimulation with a mild
amount of thapsigargin, at concentrations that did not elicit a response in WT cells. This suggests
that the shFam20C cells were already compromised in their ER Ca2+ homeostasis and were predis-
posed to Ca2+ stress-induced induction of the UPR. Together, these data (Figure 8) suggest a gen-
eral role for Fam20C in regulating ER Ca2+ homeostasis.
Discussion
We have determined the biochemical and physiological function of a kinase (Fam20C) that phos-
phorylates proteins within the lumen of the cardiac SR. Fam20C is the primary protein kinase within
a small family of putative kinases, all of which have a signal peptide that guides them to the lumen
of the ER/SR (Tagliabracci et al., 2013; Tagliabracci et al., 2015). Interest in Fam20C’s role in heart
function came from our observation that Fam20C phosphorylates HRC on Ser96 (Pollak et al.,
2017). DCM patients with the common HRC-Ser96Ala polymorphism develop deadly arrhythmias
(Arvanitis et al., 2008), likely due to loss of Fam20C phosphorylation at that site. The clinical signifi-
cance of Fam20C phosphorylation is highlighted by the fact that this polymorphism is predicted to
be present in 60% of the population (Tzimas et al., 2017), and that roughly one in 2,500 Americans
has DCM (Benjamin et al., 2018). A comparison, however, of our results with prior studies suggests
that Fam20C’s physiological roles extend beyond phosphorylation of HRC-Ser96. For example,
HRC-Ser96Ala knock-in mice were only mildly deficient in cardiac function following aging in com-
parison to HRC-Ser96 mice (Singh et al., 2013; Tzimas et al., 2017).
In addition to HRC, here we have identified multiple novel Fam20C substrates that reside in the
SR (Figures 1 and 2). While our data indicate that these phosphorylations affect SR Ca2+ homeosta-
sis, dissecting the individual contribution of each substrate is likely to be very complex and remains
to be determined. The biochemical functions of Fam20C phosphorylation remain mostly unknown
but have been demonstrated in some instances. For example, Fam20C mediated phosphorylation of
HRC regulates its binding to SERCA2a and triadin, the latter of which is important for preventing
arrhythmias (Pollak et al., 2017).
Here we show that Fam20C phosphorylation of CSQ2 increases its ability to polymerize (Figure 1).
This result is consistent with a previous report using phospho-mimetics of CSQ2 (Sanchez et al.,
2011). CSQ2 is expressed in cardiac muscle, while the closely related calsequestrin 1 (CSQ1) regu-
lates SR function in skeletal muscle (Sanchez et al., 2012). It is intriguing that CSQ2 has a disor-
dered, acidic C-terminal tail which contains an S-x-E site, but CSQ1 does not. This suggests that
CSQ2 is differentiated from CSQ1 via regulation by Fam20C phosphorylation. In response to increas-
ing amounts of Ca2+, CSQ2 transitions from a monomer to higher-ordered polymeric states
(Figure 1F) (Gyo¨rke and Terentyev, 2008). As a monomer, CSQ2 binds more effectively to triadin;
upon polymerization, it more effectively sequesters Ca2+. Therefore, Fam20C phosphorylation likely
effects CSQ2’s Ca2+ binding and its ability to bind to and regulate triadin. Interestingly, the physio-
logically critical KEKE motif of triadin (Figure 1A) contains an S-x-E site (Terentyev et al., 2005;
Kobayashi et al., 2000), whose phosphorylation status may affect triadin’s ability to bind to its pro-
tein partners: HRC, CSQ2, and RyR2. Finally, sarcalumenin, calumenin, and calreticulin regulate car-
diac function through their interactions with SERCA2a; we anticipate that their phosphorylation may
alter their interactions with SERCA2a, similarly to HRC (Pollak et al., 2017).
We also show that Fam20C mediated phosphorylation of Stim1 shifts the Ca2+ concentration
dependence of the Stim1 conformational change and thereby favors Stim1 activation (Hirve et al.,
2018) (Figure 2). Given the location of the phosphorylation on the EF-hand motif, it is likely that it
acts to modulate Stim1 Ca2+ binding, which is the basis of its activity as an ER/SR Ca2+ sensor
(Soboloff et al., 2012); alternatively, Fam20C phosphorylation may induce a structural change favor-
ing Stim1 activation. Interestingly, a recently identified mutation at the phosphorylation site (Stim1-
Ser88Gly) has been linked to cardiac dysfunction in patients; importantly, this mutation causes Ca2+
dysregulation in cells (Harris et al., 2017). This patient is one of three patients identified to date
where a mutation to Stim1’s luminal EF-hand causes cardiac dysfunction (Harris et al., 2017;
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Walter et al., 2015). However, further experimentation is necessary to directly show Fam20C medi-
ated phosphorylation of Stim1 regulates cardiomyocyte SOCE.
It is intriguing that Stim1 is widely expressed in mammals, and therefore when mutated is
involved in multiple pathological roles (Soboloff et al., 2012), further suggesting a broad regulatory
function for Fam20C in ER/SR Ca2+ regulation (Figure 8) that is likely to be a general mechanism in
all cells, which can be addressed by future studies. This is an extension of the previously appreciated
role of Fam20C in the phosphorylation of only secreted proteins, and this extension is in-line with a
recent report showing Fam20’s role in regulating ER redox homeostasis (Zhang et al., 2018).
Physiologically, we show that loss of murine cardiomyocyte Fam20c causes accelerated deteriora-
tion of cardiac function following various pathological stimuli, including aging, TAC, and isoprotere-
nol infusion (Figures 5–7). These severe functional consequences are likely due to loss of SR luminal
protein phosphorylation. The mild alterations in cardiomyocyte performance (Figure 3) and pressure
development (Figure 4) at baseline (2 months old) – where no functional abnormalities were
observed (Figure 5) – foreshadow the significant defects found in cardiomyocyte function and car-
diac contractility and relaxation following aging which accompanies heart failure. Fam20C has not
been previously demonstrated to phosphorylate SR Ca2+ handling proteins or play a critical role in
stress-induced heart failure development. There is broad precedent for this general concept, how-
ever, as CaMKII mediated RyR2 phosphorylation (Ling et al., 2009) and PKA mediated phospholam-
ban phosphorylation (Braz et al., 2004) have established roles in the development of heart failure.
In summary, we present protein phosphorylation by Fam20C within the lumen of the ER/SR as an
important regulatory mechanism that controls cellular Ca2+ homeostasis and cardiac pathophysiol-
ogy. Most strikingly, aging led to significantly worsened systolic and diastolic function, associated
with interstitial fibrosis, in Fam20C cKO mice. Interestingly, in adult patients, approximately 50% of
those suffering from congestive heart failure display a preponderance of diastolic dysfunction, often
associated with myocardial fibrosis as they age (Ouzounian et al., 2008). By establishing Fam20C as
a regulator during aging of myocardial form and function, this study portends an important molecu-
lar biologic role for Fam20C in the modern epidemic of congestive heart failure.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Antibody Mouse
monoclonal
M2 FLAG
Sigma A2220-5 ml,
RRID:AB_
439685
(1:100)
Antibody Rabbit
polyclonal
anti-Flag
Sigma F7425-.2MG,
RRID:AB_
796202
(1:1000)
Antibody Rabbit
polyclonal
anti-Stim1
Cell Signaling 4916S,
RRID:AB_
1849882
(1:1000)
Antibody Rabbit
polyclonal
anti 6x-His
Thermo Fisher MA1-21315-
HRP,
RRID:AB_
10977997
(1:2000)
Antibody Rabbit
polyclonal
anti Bip/
GRP78
Abcam ab21685,
RRID:AB_
880312
(1:1000)
Antibody Rabbit
polyclonal
anti Calseq
uestrin 2
Thermo Fisher PA1-913,
RRID:AB_2
540244
(1:5000)
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Antibody Mouse
monoclonal
anti GAPDH
Calbiochem CB1001 (1:10000)
Antibody Mouse
monoclonal
anti PARP
(cleaved)
Cell Signaling 9541S,
RRID:AB_
2160592
(1:1000)
Antibody Rabbit
polyclonal
anti Fam20C
Tagliabracci et al., 2013
Tagliabracci et al., 2013
(1:5000)
Chemical
compound, drug
Trizol Thermo Fisher 15596026
Chemical
compound, drug
Esmolol abcam ab146018
Chemical
compound, drug
Dobutamine abcam ab120768
Chemical
compound, drug
Thapsigargin Thermo Fisher 586005–
1 MG
Chemical
compound, drug
32P-ortho
phosphate
PerkinElmer NEX05
3010MC
Chemical
compound, drug
Gamma 32P ATP PerkinElmer BLU002
Z001MC
Chemical
compound, drug
Fura-2, AM,
cell permeant
Thermo Fisher F1221
Software,
algorithm
Graph Pad Prism Version 7
Sequence-based
reagent
RT-qPCR primers this paper Table 1
Genetic reagent
(M. musculus)
Fam20c Fl/+ inGenious
Targeting
Laboratory
Commercial
assay or kit
iScript cDNA
Synthesis kit
BioRad 1708891
Commercial
assay or kit
nucleospin
RNA kit
MACHEREY-
NAGEL
740955.25
Commercial
assay or kit
ApopTag
Peroxidase
In Situ Apoptosis
Detection
Millipore
Sigma
S7100
Cell line
(homo sapiens)
HEK293T Tagliabracci et al., 2013
Tagliabracci et al., 2013
RRID:CVCL_6910
Cell line
(homo sapiens)
HeLa Hirve et al., 2018 RRID:CVCL_0030
Cell line
(homo sapiens)
U2OS
(WT/shFam20C)
Tagliabracci et al., 2013
Tagliabracci et al., 2013
RRID:CVCL_0042
Cell line
(rattus norvegicus)
H9C2 ATCC CRL-1446, RRID:CVCL_0286
Mouse model
Fam20c Fl/+ mice were generated by inGenious Targeting Laboratory (Ronkonkoma, NY). Briefly,
exons 6–10 were flanked by two LoxP sites in the Fam20c-targeting vector. A neomycin-resistant
gene cassette located within the two LoxP sites was flanked by two Frt sites. The targeting vector
was subsequently electroporated into ES cells. Targeted iTL BA1 (C57BL/6  129/SvEv) hybrid
embryonic stem cells were microinjected into C57BL/6 blastocysts. Resulting chimeras with a high
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percentage of agouti coat color were mated to C57BL/6 FLP mice to remove the Neo cassette.
Resulting Fam20c Fl/+ mice were further backcrossed onto a C57BL/6 background for greater than
four generations. Tail DNA was analyzed for genotyping using the following primers: F: 5’-TTATC
TGCTCATGTGCGTATGTGG-3’; R: 5’-TACAGAGCAGAACTCCAGCCACTG- 3’.
Transgenic mice expressing Cre recombinase under the control of the a-myosin heavy chain pro-
moter (Agah et al., 1997) (a-myh6) on a C57BL/6 background were genotyped using tail DNA with
the following primers: F: 5’-GCGGTCTGGCAGTAAAAACTATC-3’; R: 5’-GTGAAACAGCATTGCTG
TCACTT-3’. Only male mice were used for experiments. WT and cKO mice were littermates and
cage mates. Researchers performing tests and collecting data were blinded during experiments.
Mice were housed in a specific pathogen-free facility with a 12 hr light and a 12 hr dark cycle, and
given free access to food and water. All animal uses were approved by the Institutional Animal Care
and Use Committee (IACUC) at the University of California-San Diego.
Induced pressure overload models
For Transverse Aortic Constriction (TAC), Adult mice were anesthetized with ketamine (50 mg/kg)
and xylazine (5 mg/kg) by intraperitoneal (IP) injection for initial induction and then isoflurane (0.75–
1.5%) for complete induction of anesthesia. The chest cavity was entered in the second intercostal
space at the left upper sternal border and the transverse aorta was isolated between the carotid
arteries. Aortic constriction was performed by tying a 7–0 silk suture ligature against a 27–27.5-
gauge needle (according to the body weight), and the needle was then promptly removed to yield a
constriction of about 0.4 mm in diameter. Following the constriction procedure, the chest was closed
with 6–0 silk sutures. Buprenorphine (0.1 mg/kg) (100 ml/mouse) was given 15–30 min prior to antici-
pated recovery.
For Isoproterenol infusion, mice were anesthetized with 5% isoflurane for 45 s and then main-
tained at 0.5% isoflurane throughout the implantation of the Alzet osmotic pumps (Durect Corp,
Cupertino, CA). Mice received 30 mg/kg/day of isoproterenol for 14 days.
Invasive hemodynamic analysis
A 1.4F micromanometer catheter (Millar Inc., Houston, TX) was inserted retrograde into the aorta via
the right carotid artery and advanced into the left ventricle in anesthetized mice (100 mg/kg of keta-
mine and 10 mg/kg of xylazine), intraperitoneal (IP) that were intubated (100–110 strokes/minute,
0.04–0.05 ml/stroke volume). A femoral vein was cannulated with a stretched PE50 tubing for drug
administration. Baseline pressure measurements were obtained. Then, graded dobutamine doses of
0.75, 2, 4, 6, and 8 mg/kg/min, or graded Esmolol doses of 10, 20, and 30 mg/kg/min, were deliv-
ered using an infusion pump (PHD 2000, Harvard Apparatus, Holliston, MA) for 3 min at each dose.
Data were reported after bilateral vagotomy. LV hemodynamic parameters were recorded and
Table 1. qRT-PCR primers.
m corresponds to mouse, h corresponds to human.
Gene Forward Reverse
mANP TCGTCTTGGCCTTTTGGCT TCCAGGTGGTCTAGCAGGTTCT
mBNP AAGTCCTAGCCAGTCTCCAGA GAGCTGTCTCTGGGCCATTTC
mb-MCH ATGTGCCGGACCTTGGAAG CCTCGGGTTAGCTGAGAGATCA
mCol1a1 GAGAGAGCATGACCGATGGATT GCTACGCTGTTCTTGCAGTGAT
mCol 3a1 CAGCAGTCCAACGTAGATGAATTG CATGGTTCTGGCTTCCAGACA
ma-SMA TCCTGACGCTGAAGTATCCG GGCCACACGAAGCTCGTTAT
mCTGF AATCTCCACCCGAGTTACCA AACTTAGCCCTGTATGTCTTCAC
mFam20C AACATGGATCGGCATCACTAC AGGAGCGAGAATGGAAAGC
mGAPDH CACCATCTTCCAGGAGCGAG CCTTCTCCATGGTGGTGAAGAC
hCHOP GTCTAAGGCACTGAGCGTATC CAGGTGTGGTGATGTATGAAGA
hGAPDH ACATCGCTCAGACACCATG TGTAGTTGAGGTCAATGAAGGG
DOI: https://doi.org/10.7554/eLife.41378.014
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analyzed using LabChart (ADInstruments, Inc., Colorado Springs, CO), including peak LV pressure,
LV end-diastolic pressure (EDP), LV dP/dt max (an index of myocardial contractility), LV dP/dt min,
and Tau (time constant of LV relaxation).
Transthoracic echocardiography
Prior to echocardiography, a depilatory cream was applied to the anterior chest wall to remove the
hair. Mice were anesthetized with 5% isoflurane for 15 s and then maintained at 0.5% throughout
the echocardiography examination. Small needle electrodes for simultaneous electrocardiogram
were inserted into one upper and one lower limb. Transthoracic echocardiography (M-mode and 2-
dimensional echocardiography) was performed using the FUJIFILM VisualSonics Inc., Vevo 2100
high-resolution ultrasound system with a linear transducer of 32-55MHz. Measurements of chamber
dimensions and wall thicknesses were performed. Percentage fractional shortening (%FS) was used
as an indicator of systolic cardiac function.
Adult cardiomyocyte isolation
The hearts were removed following isoflurane anesthesia and rinsed in Krebs-Henseleit buffer B
(KHB-B) (118 mM NaCl, 4.8 mM KCl, 25 mM HEPES, 1.25 mM K2HPO4,
1.25 mM MgSO4, 11 mM glucose, pH 7.4). The hearts were cannulated through the aorta and
perfused on a Langendorff apparatus with a KHB solution (3 ~ 5 min, 37˚C), then a KHB enzyme solu-
tion (1.5 mg/ml Collagenase Type 2, 25 mM Blebbistatin) for 12 min at 37˚C. After digestion, the
hearts were perfused with 5 ml KHB solution to wash out collagenase. Then the hearts were minced
in KHB solution, gently agitated, then filtered through a 100 mm polyethylene mesh. After settling,
cells were washed once with KB solution, and stored in KB solution at room temperature before use.
Cell shortening/re-lengthening and Ca2+ transient studies
Adult cardiomyocytes were loaded with Fura-2-AM (1.0 mM, 20 mins), washed twice, and continu-
ously perfused with Tyrode solution maintained at 37˚C. Simultaneous measurement of intracellular
Ca2+ ([Ca2+]i) and cell contractility was assessed by using a video-based edge-detection system (Ion-
Optix, Milton, MA). Briefly, cardiomyocytes were field stimulated at a frequency of 0.5 Hz using a
pair of platinum wires placed on the opposite sides of the dish chamber and connected to a Myo-
Pacer Field Stimulator (IonOptix). The cardiomyocytes being studied were displayed on the com-
puter monitor using an IonOptix MyoCam camera. 15–25 individual myocytes were recorded and
analyzed for each heart. The ratio of Fura-2 fluorescence at 340 nm and 380 nm (R) was calculated
and the amplitude of intracellular Ca2+ transient was determined by the change between the basal
and peak ratio (DR). The amplitude of cell contraction was assessed by % change of peak shortening,
and the rate of cell relaxation was assessed by the time to 63% re-lengthening (Tau).
Cloning
Human cDNAs were purchased from either Open Biosystems or DNASU. For transient expression in
mammalian cells, full-length CSQ2, Stim1, triadin, Fam20C, calumenin, calreticulin, and sarcalume-
nin, were cloned into pCCF with a C-terminal Flag tag. Fam20C (WT and D478A) was cloned into
pCDNA3 with a C-terminal HA-tag. For recombinant expression in E. coli, CSQ2 (19–399) and Stim1
(22-201) were cloned into pET28 vector with a C-terminal 6X-His tag. For insect cell expression,
Fam20C (93–584) was cloned into a modified pI-secSUMOstar vector (LifeSensors, Malvern, PA), in
which the original SUMO tag was replaced by a MBP tag and a tobacco etch virus (TEV) protease
site as previously described (Xiao et al., 2013). Site-directed mutagenesis was performed using
QuikChange (Agilent Technologies, Santa Clara, CA). All the constructs were verified by DNA
sequencing.
Protein expression and purification
MBP-tagged Fam20C protein was expressed in Hi-5 insect cells and was purified as described previ-
ously (Xiao et al., 2013). The MBP tag was removed via gel filtration chromatography following TEV
protease cleavage. Indicated Flag-tagged constructs were transiently expressed in HEK293 or H9C2
cells and were immunopurified from cell lysates as previously described (Pollak et al., 2017).
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His-CASQ2 and His-Stim1 were expressed in E. coli BL21 (DE3) –RILP cells. Cultures were grown
at 37˚C to an OD600 of 0.6–0.8 and expression was induced by addition of isopropyl-b-D-1-thiogalac-
topyranoside (IPTG) to 400 mM. Induced cultures were grown at 25˚C overnight and cells were har-
vested by centrifugation at 4,680  g for 15 min. Cell pellets were suspended in lysis buffer (50 mM
Tris-HCl pH 8.0, 500 mM NaCl, 15 mM imidazole, 10% glycerol, 0.1% Triton X-100, and 10 mM b-
mercaptoethanol) and lysed via sonication. The lysate was cleared by centrifugation at 11,950  g
for 45 min. The cleared lysate was incubated with Ni-NTA agarose (Invirogen) for 20 min on ice and
poured through a gravity column. The beads and bound protein were washed with wash buffer (50
mM Tris-HCl pH 8.0, 500 mM NaCl, 15 mM imidazole, 10 mM b-mercaptoethanol). Protein was
eluted from the column in wash buffer containing 400 mM imidazole.
Mammalian cell culture, transfection, and 32P orthophosphate
metabolic labeling
HEK293 cells, U2OS cells, and H9C2 rat cardiomyoblast cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM; Life Technology) supplemented with 10% FBS (Life Technology) and 100
mg/ml penicillin/streptomycin (Life Technology) at 37˚C in a 5% CO2 incubator. The identity of the
human cell lines were confirmed by STR profiling (Sanford Burnham Prebys Medical Discovery Insti-
tute, La Jolla) and all the cells tested mycoplasma-free via PCR. Transfection was carried out by using
FuGENE-6 (Promega, Madison, WI) following the manufacturers’ instructions. For metabolic radio-
labeling experiments, HEK293 or H9C2 cells were seeded at 5  105 cells per well in 6-well plate; 20
hr later, cells were transfected with the indicated plasmids. 1 day after transfection, metabolic label-
ing was started by replacing the medium with phosphate-free DMEM containing 10% dialyzed FBS
and 1 mCi/ml 32P orthophosphate (PerkinElmer, Waltham, MA). After labeling for 8 hr, the cell lysate
was collected and the cell debris was removed by centrifugation. Flag-tagged proteins were immu-
noprecipitated from the supernatant and analyzed for protein and 32P incorporation by immunoblot-
ting and autoradiography.
In vitro phosphorylation assays
For the in vitro kinase assays substrates were purified from bacteria and Fam20C was purified from
insect cells, and the proteins were incubated in 50 mM Tris pH 7.0, 10 mM MnCl2, 1 mM [g-
32P] ATP
(specific activity = 100–500 cpm/pmol), 0.25 mg/mL substrate, and 10 mg/mL Fam20C at 30˚ C as
previously described (Tagliabracci et al., 2012). Reactions were terminated at the indicated time
points by SDS loading buffer, 15 mM EDTA, and boiling. Reaction products were separated by SDS-
PAGE and incorporated radioactivity was visualized via autoradiography and immunoblotting.
Histology
Hearts were isolated from mice, washed with PBS and fixed for 24 hr in a 10% Formalin. The hearts
were then placed in 70% ethanol and were submitted to the University of California, San Diego his-
tology core for paraffin embedding and sectioning for H and E and Masson’s Trichrome staining.
The Tunel assay was performed using the ApopTag Peroxidase In Situ Apoptosis Detection Kit per
the manufacturer’s instructions. Slides were scanned via the AT2 Aperio Scan Scope. Masson’s Tri-
chrome and Tunel stained slides were analyzed in five high powered fields (HPF) per sample by a his-
tologist blinded to genotype.
Turbidity assay
For the turbidity assay, His-CASQ2 was phosphorylated by direct addition of ATP, MnCl2, and
FAM20C to the eluted sample (above). The final reaction conditions contained 50 mM Tris-HCl pH
8.0, 500 mM NaCl, 400 mM imidazole, 10 mM b-mercaptoethanol, 1 mM ATP, 1 mM MnCl2, and ~1
mg/mL FAM20C. Saturated phosphorylation (>95%) was demonstrated by removing a small portion
of the reaction, adding radioactive ATP [g-32P], and observing a plateau of time-dependent incorpo-
ration of radioactive phosphate via SDS-PAGE and autoradiography (not shown). The unphosphory-
lated protein was treated in tandem under identical conditions but excluding Fam20C. Reactions
were quenched after 4 hr by the addition of EDTA to 10 mM.
The phosphorylated and control protein was dialyzed against TG buffer (10 mM Tris-HCl pH
7.0%–10% glycerol). Samples were concentrated to 1 mL and purified further with size exclusion
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chromatography. The protein was loaded onto a HiLoad 16/600 Superdex 200 pg column (GE
Healthcare) and eluted in TG buffer. Elution was monitored by absorbance at 280 nm and peak frac-
tions were analyzed with SDS-PAGE followed by Coomassie blue staining. Fractions containing
homogenous CASQ2 were pooled and used for further analysis.
Turbidity assays were performed by combining either phosphorylated or unphosphorylated His-
CASQ2 protein with CaCl2 in TG buffer at a 1:1 ratio to yield final reaction mixtures containing 4.5
mM CASQ2, 10 mM Tris-HCl pH 7.0, 10% glycerol, and CaCl2 at the concentrations indicated. The
mixtures were incubated at room temperature for 30 min with gentle shaking and 200 mL of the indi-
vidual reactions were transferred to a transparent Nuclon 96-well plate (Thermo). The turbidities of
the samples were determined by measuring the absorbance at 350 nM in Infinite M200 Pro plate
reader (Tecan).
Single-cell Ca2+ influx assay
Single-cell Ca2 +imaging was performed using HeLa cells that had been transfected with either
Fam20C WT or Fam20C KI plasmid, and non-transfected HeLa cells. The cells were loaded with 5
mM Fura-2-acetoxymethyl ester for 45–60 min at 37˚C in DMEM containing 0.02% Pluronic F-127
and 10 mM HEPES pH 7.4, washed twice with fresh media, and analysed immediately. Modified
Ringer’s solution used in this assay consisted of 125 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, 10 mM
D-glucose, and 20 mM HEPES (pH 7.4 with NaOH), with the addition of 2 mM CaCl2, or 1 mM thapsi-
gargin (TG), where indicated. Coverslips were assembled into a chamber on the stage of an Olym-
pus IX 71 microscope equipped with an Olympus UPLSAPO 20, NA 0.75, objective. Cells were
alternately illuminated at 340 nm and 380 nm with the Polychrome V monochromator (TILL Photon-
ics) using ET - Fura2 filter (Chroma Technology Corp., catalog number 79001). The fluorescence
emission at l >400 nm (LP 400 nm, Emitter 510/80 nm) were captured with a CCD camera (Sensi-
Cam, TILL Imago). Ratio images were recorded at intervals of 4 s. Ca2+ concentration was estimated
from the relation (Grynkiewicz et al., 1985): [Ca2+]i = Kd ((R Rmin)/(Rmax R)) (Sf2/Sb2), where
Kd = 220 nM, and the values of Rmin, Rmax, and (Sf2/Sb2) were determined from an in situ calibration
of Fura-2 in HeLa cells. Data were analyzed using TILL Vision (TILL Photonics).
Stim1 Ca2+ concentration-dependent crosslinking assay
HeLa cells were co-transfected with Stim1(A230C) and Fam20C WT, or with Stim1(A230C) and
Fam20C KI plasmids. The crosslinking was performed as described previously (Hirve et al., 2018).
Briefly, the cells (~12106) were scraped from the substrate and resuspended in Chelex-treated dilu-
tion buffer with no added EGTA or Ca2+. Cellular membranes were prepared and apportioned to
twelve wells containing resuspension buffer supplemented to give either a final EGTA concentration
of 0.5 mM or final Ca2+ concentrations ranging from 0.3 mM to 2 mM. Iodine oxidation, nonreducing
SDS-PAGE analysis, and immunoblotting using anti-Stim1 antibody were performed as described
previously (Hirve et al., 2018).
ER Ca2+handling
ER Ca2+ release was quantified following treatment with 2 mM Thapsigargin induced ER Ca release
using the dual wavelength ratiometric cytosolic Ca dye, Fura2-AM (Invitrogen), on the FLEX-Station
(Molecular Devices) (Marshall et al., 2006) in a 96-well plate format with 3–6 replicates per sample,
as previously described (Wiley et al., 2013). Minimum and maximum signal intensities were deter-
mined for each run. Ratiometric measurements were converted to intracellular [Ca2+] using the fol-
lowing equation: [Ca2+]=Kd[(R-Rmin)/(Rmax-R)](F380max/F380min).
Cardiac fractionation
For generating the whole tissue lysate, freshly isolated hearts were homogenized in a buffer contain-
ing 50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 0.5% NP-40, 10% glycerol, 0.5 mM EDTA, and a prote-
ase inhibitors cocktail. To enrich the ER/Golgi, hearts were homogenized in HME buffer containing
10 mM Tris–HC (pH 7.4), 250 mM sucrose, 1 mM EDTA, and a protease inhibitors cocktail. The
homogenate was centrifuged at 1000xg to remove nuclei and unbroken cells. The supernatant was
centrifuged at 3000xg to pellet heavy mitochondria. The 3000xg supernatant was then centrifuged
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at 17,000xg to pellet the ER, Golgi and light mitochondria. This pellet was resuspended in HME
buffer as the ER/Golgi-enriched fraction.
Antibodies
The following antibodies were used in for protein immunoprecipitation or immunoblotting: mouse
anti-Flag M2 (Sigma), rabbit anti-Flag (Sigma), anti-GAPDH (Calbiochem), rabbit anti-Stim1 (Cell Sig-
naling), anti-Bip/GRP78 (Abcam), anti-PARP (cleaved) (Cell Signaling), anti-Calsequestrin 2 (Thermo),
anti-Fam20C (Tagliabracci et al., 2014), and anti-His (Invitrogen).
Statistics
All data are shown as mean ±SEM. Replicates are indicated in figure legends, with n representing
the number of experimental replicates. When comparing two groups, two tailed Student’s t test was
performed. Statistical analysis was performed using GraphPad Prism 6.0 (GraphPad Software).
p < 0.05 was considered statistically significant.
qRT-PCR
For qRT-PCR analysis, total RNA from cardiac tissue was isolated from using Trizol (Invitrogen) per
the manufacturer’s instructions. For Chop expression analysis, total RNA was isolated cells using the
NucleoSpin RNA kit (MACHEREY-NAGEL, Bethlehem, PA). cDNA was synthesized using the iScript
kit (Bio-Rad). qRT-PCR analysis was performed using the Power SYBR Green PCR Master Mix
(Applied Biosystems, Waltham, MA) on Applied Biosystems 7500 Real-Time PCR System. Data were
normalized to corresponding GAPDH levels. The indicated primers were used (Table 1).
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